Table 1.
Molecular mechanisms and therapeutic potential of exosomal ncRNAs involved in diabetic wound healing.
| Exo-ncRNAs | Molecular mechanisms | Final effect | Ref. | 
|---|---|---|---|
| miR-223 | Regulate macrophage polarization by targeting pknox1 | Reduce inflammatory response | (11) | 
| miR-let-7b | convert the polarization of macrophage via TLR4/NF-κB/STAT3/AKT signaling pathways | Reduce inflammatory response | (28) | 
| miR-135a | Inhibit E-cadherin, N-cadherin, and LATS2 and promote α-SMA expression | Promote fibroblasts migration | (33) | 
| miR-146a | Upregulate SERPIN and p-ERK2 expression in fibroblasts | Promote fibroblasts migration | (29) | 
| miR-221-3p | Increase the expression of VEGF, CD31, and Ki67 involved in AGE-RAGE and p53 signaling pathway, cell cycle | Promote vascular cells proliferation | (38) | 
| miR-126 | activate the PI3K/AKT signaling pathway via miR-126-mediated PTEN downregulation | Promote angiogenesis | (30) | 
| miR-21、-23a、-125b、-145 | Inhibit TGF-b2, TGF-bR2, and SMAD2 and suppress α-SMA and collagen I expression | Anti-scarring effect | (31) | 
| lncRNA-H19 | Impair miR-152-3p-mediated PTEN inhibition | Inhibit apoptosis and inflammation, promote fibroblasts migration | (52) | 
| lncRNA KLF3-AS1 | Decrease miR-383 expression and upregulate VEGFA | Increase angiogenesis, reduced inflammation | (56) | 
| lncRNA NEAT1 | mediate Wnt/β-catenin signaling pathway | Increase angiogenesis | (51) | 
| circKlhl8 | Activate miR-212-3p/SIRT5 signaling pathway | Increase survival and maintain endothelial function in EPCs  | 
(71) | 
| mmu circ 0000250 | Induce miR-128-3p/SIRT1 mediated autophagy  | 
Increase angiogenesis and autophagy | (72) |